Vericel (VCEL) News
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
57.52-0.74 (-1.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VCEL news summary
We found 15 recent headlines mentioning Vericel (VCEL): 4 in the past week and 13 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, VCEL is down 1.27% at $57.52. The most recent story, "REGN Gets FDA Nod for Livsayis in Generalized Myasthenia Gravis", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Vericel headlines
- REGN Gets FDA Nod for Livsayis in Generalized Myasthenia GravisRegeneron's Livsayis becomes the first and only siRNA therapy approved by the FDA for generalized myasthenia gravis, offering four subcutaneous doses a year.NasdaqREGN, ALNY, VCEL, ETON
- NVS Gets FDA Nod for Cosentyx in Adults With Polymyalgia RheumaticaNovartis wins FDA approval for Cosentyx in adults with PMR, backed by phase III data showing sustained remission and steroid-sparing benefits.NasdaqNVS, VCEL, ETON
- J&J to Boost Ophthalmology Pipeline With $2.2B Ollin AcquisitionJNJ's $2.2 billion Ollin acquisition adds a phase III eye disease candidate to its pipeline, with Blackstone providing $750 million to fund the development.NasdaqJNJ, COLL, VCEL
- Novartis' Cosentyx Gets Positive CHMP Opinion for Adolescents With HSNVS' Cosentyx gains a positive CHMP recommendation for adolescents with moderate to severe HS, potentially expanding treatment options in Europe.NasdaqNVS, COLL, VCEL, KROS
- Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026BURLINGTON, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the…GlobeNewswire
- Pfizer Secures Up to $1.5B Funding From Blackstone for Obesity ProgramPFE gets up to $1.5 billion from Blackstone to fund berobenatide's development through 2028, retaining full control of the obesity program.NasdaqPFE, COLL, VCEL, AMRX
- Vericel Q3 Earnings Call Highlights3 Major Earnings Winners You May Have MissedVericel (NASDAQ:VCEL) raised its full-year revenue and profitability outlook after third-quarter sales rose 26%, led by growth in its MACI cartilage repair…Nasdaq
- Vericel forecasts $344M-$346M 2026 revenue while raising adjusted EBITDA margin guidance to ~28%Seeking Alpha
- Vericel Corporation Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial GuidanceVericel Corporation reported its financial results for the third quarter ended September 30, 2026, with total net revenue increasing 26% to $85.4 million compared to $67.5 million in the third…Nasdaq
- Vericel Corp (VCEL) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Vericel Q3 Profit Surges, Lifts FY26 Outlook; Shares Jump In Premarket(RTTNews) - Advanced therapies company Vericel Corp. (VCEL) on Thursday reported a surge in third-quarter profit, driven by higher sales compared to a year earlier.Nasdaq
- Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial GuidanceTotal Revenue Growth of 26% to $85.4 Million Net Income Increased 179% to $14.2 Million Adjusted EBITDA Margin of 30% Raised Full-Year Revenue Guidance to $344 to $346 Million and Adjusted EBITDA…GlobeNewswire
- Vericel Q3 2026 Earnings PreviewSeeking Alpha
- Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026BURLINGTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the…GlobeNewswire
- Noteworthy Wednesday Option Activity: SLAB, VCEL, MDGLAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Silicon Laboratories Inc (Symbol: SLAB), where a total of 8,212 contracts have traded so…NasdaqSLAB, VCEL, MDGL